Detailed Description
The endpoints of the ranges and any values disclosed herein are not limited to the precise range or value, and such ranges or values should be understood to encompass values close to those ranges or values. For ranges of values, between the endpoints of each of the ranges and the individual points, and between the individual points may be combined with each other to give one or more new ranges of values, and these ranges of values should be considered as specifically disclosed herein.
In the present invention, without making a reference to the terms herein, the term "siderophore" is used to refer to a small molecule compound having a chelating effect on iron elements, the "siderophore-producing strain" refers to a microorganism capable of efficiently synthesizing siderophores, the "fermentation metabolite" refers to a strain that secretes many metabolites by fermentation, and the "bacteriostatic activity" refers to an activity of inhibiting or retarding growth of phytopathogens.
The preservation number of the trichoderma provided by the invention is CGMCC No. 21023.
The Trichoderma 2-14F2 strain of the present invention is specifically classified into Deuteromycotina, Hyphomycetes, Moniliales, Moniliaceae, Trichoderma. The bacterium has high siderophore activity which is higher than the reported literature data, and the related data are shown in table 1.
Table 1: comparison of siderophore production types and Activities of 2-14F2 Strain
The invention provides a quantitative analysis method for verifying the activity of a strain siderophore, which comprises the following steps: the 2-14F2 strain is inoculated in a culture medium for culture.
According to the present invention, the medium may be a solid medium, which may be a conventional medium capable of being suitable for growth of trichoderma. Preferably the solid medium contains: 400g of potato, 20-40g of glucose, 18-36g of agar, 1-2L of deionized water and pH of 7.0. The color developing agent contains: CAS detection liquid (0.0605g chromium azure S, 1 mmol. L)-1FeCl3·6H2O+10mmol·L-1HCl, deionized water, etc.). The liquid medium contains: glucose 30.0-60.0 g.L-1Sodium nitrate 2.0-40.0 g.L-11.0-2.0 g.L of potassium phosphate trihydrate-10.5-1.0 g.L of potassium chloride-1Magnesium sulfate heptahydrate 0.5 g.L-10.75-1.5 g.L of 8-hydroxyquinoline-1And 1.0-2.0L of deionized water.
According to the present invention, preferable conditions for the culture of the strain include: the preferred temperature is 25-30 deg.C, and the preferred incubation time is 75-120 h.
The invention provides a specific method for strain expansion and fermentation culture and provides a material for activity research of 2-14F2 strain fermentation metabolites.
According to the present invention, the 2-14F2 strain provided is not particularly required for the conditions of expansion and fermentation culture, but preferably, steamed rice is autoclaved and placed in a tissue culture bottle, and Trichoderma 10 is inoculated per 10g of steamed rice7-109CFU (e.g. 10)8CFU) and culturing at 25-30 deg.C in dark for 30-60 days.
According to the present invention, the method may further comprise subjecting the culture product to an extraction operation to obtain the hydroxamic acid type siderophore therefrom. The extraction operation may be performed by methanol leaching, i.e., by soaking the culture product with methanol.
The strain provided by the invention is a 2-14F2 strain with high siderophore activity, the metabolite of the strain is effectively extracted through fermentation and expanded culture of the strain, and in order to verify the bacteriostatic function of the metabolite, phytopathogens such as tomato bacterial wilt, potato bacterial wilt, tobacco bacterial wilt and the like are selected for bacteriostatic activity determination.
According to the invention, the 2-14F2 strain with the preservation number of CGMCC No.21023 has the ability of secreting hydroxamic acid type siderophore and inhibiting or hindering the normal growth of a plurality of plant pathogenic bacteria, but preferably has outstanding bacteriostatic activity on pseudomonas solanacearum, and can realize the purpose of preventing and treating plant bacterial wilt.
Accordingly, the present invention also provides a method for controlling plant diseases (or promoting plant growth), characterized in that the method comprises applying a preparation containing a metabolite of trichoderma as described above to plants.
According to the invention, the metabolite may be provided by a culture of the 2-14F2 strain. That is, the metabolite of the 2-14F2 strain can be prepared as described above, specifically, the 2-14F2 strain is inoculated into a rice medium and cultured. The method may further comprise subjecting the culture product to an extraction operation to obtain therefrom the hydroxamic acid type siderophore and the bacteriostatic active substance. According to a preferred embodiment of the present invention, the conditions for the cultivation are as described above and will not be described herein.
According to another preferred mode of the present invention, the culture is performed in a liquid medium, and the conditions of the culture are as described above and will not be described herein.
In the invention, Fe is added into the preparation3+The bacteriostatic activity of the strain is obviously reduced, which shows that the activity of the siderophore in the strain is closely related to the bacteriostatic activity. Thus, preferably, the formulation is free of ferric ions, i.e. the method does not comprise the step of applying an agent comprising ferric ions to the plants.
According to the present invention, the plant may be various crops, preferably a plant susceptible to bacterial wilt, more preferably, the plant is selected from at least one of tomato, potato and tobacco.
According to the invention, the metabolite of the strain has outstanding bacteriostatic activity on pathogenic bacteria of tomato bacterial wilt, potato bacterial wilt and tobacco bacterial wilt, therefore, the plant disease is preferably selected from plant diseases caused by at least one of pseudomonas solanacearum, pectobacterium carotovorum and ralstonia solanacearum.
The invention also provides the application of the trichoderma in preparing the hydroxamic acid siderophore.
The invention also provides application of the trichoderma and/or the metabolite thereof in preventing and treating plant diseases (plant bacterial wilt). As described above, the plant disease is preferably selected from plant diseases caused by at least one of Pseudomonas solanacearum, Pectibacterium carotovorum and Ralstonia solanacearum.
The invention also relates to the use of a Trichoderma strain and/or metabolite thereof as described above for inhibiting at least one of Pseudomonas solanacearum, Pectibacterium carotovorum and Ralstonia solanacearum.
The pseudomonas solanacearum, the pectobacter carotovora and the ralstonia solanacearum can be obtained by self-separation and can also be obtained commercially.
The present invention will be described in detail by the following examples. In the following examples, Pseudomonas solanacearum is purchased from Biotechnology Ltd, Baiopabo great, Beijing, under the number bio-51812; the carrot soft rot pathogen (carrot soft rot pectobacterium) is purchased from Beijing Baiohbowei biotechnology, Inc., and numbered bio-02810; ralstonia reyeri was purchased from Beijing Baiohbowei Biotechnology Inc., and numbered bio-103869.
Example 1
This example illustrates the results of morphological and molecular genetic taxonomic identification of the strains according to the invention.
A fungus is separated from original forest soil (100 degrees 49'-101 degrees 53' E, 23 degrees 95'-24 degrees 17' N, elevation 2600m) in national natural reserve of the Lailaishan mountain in Yunnan province, and is preserved in the common microorganism center of China Committee for culture Collection of microorganisms with the preservation number of CGMCC No. 21023.
The strain 2-14F2 is cultured on a plate culture medium (300 g of potato, 30g of glucose, 27g of agar, 1.5L of deionized water and pH 7), the colony morphology is round, light green and opaque, and villous hyphae are on the surface of the colony; after the scanning electron microscope is magnified by 21000 times, the conidia are closely spaced and round, the diameter is 1.5um-2.5um, and the surfaces of the conidia are wavy and uneven (see figure 1). Based on morphological observation, the ITS sequencing result of the strain is subjected to similarity search in a Gen Bank database, and is subjected to homology comparison with a standard strain sequence with homology higher than 80%, and the homology with Trichoderma yunnanense (NR 134419) is up to 99.86% (see figure 2), so that the strain is identified as a microorganism of Deuteromycotina, Hyphomycetes, Moniliales, Moniliaceae and Trichoderma.
Example 2
This example illustrates the siderophore capacity of the strains to which the invention relates.
(1) Culture of test tube species
Inoculating 2-14F2 strain on solid slant culture medium, and culturing at 25 deg.C for 80 hr to obtain test tube strain; the formula of the solid culture medium is as follows: 300g of potato, 30g of glucose, 27g of agar, 1.5L of deionized water and pH 7;
(2) solid plate seed culture
The plate culture medium is adopted for culture, and the method comprises the following steps:
preparing an iron-free Chachi solid culture medium: glucose 30.0 g.L-1Sodium nitrate 2 g.L-1 Potassium phosphate trihydrate 1 g.L-10.5 g.L of potassium chloride-1Magnesium sulfate heptahydrate 0.5 g.L-10.75 g.L of 8-hydroxyquinoline-11L of deionized water, and 18g of agar added to the solid.
Double-layer chromogenic medium: the lower layer: 100ml of deionized water, 1.8g of agar and 15ml of CAS solution; and (3) upper layer: iron-free Chachi solid culture medium. The 2-14F2 strain was inoculated on a double-layer plate medium, and the appearance of red color indicated that the strain secreted siderophores. As shown in FIG. 1B, a red halo appeared around the colony, indicating that the strain secretes siderophores.
(3) Quantitative determination of siderophore activity of the strain
Culturing the strain with non-iron Chachien liquid on a constant temperature shaking table (model: HS-200B) at 28 deg.C and 150r/min for 5 days, sucking 3mL of culture solution after culturing, filtering with 0.22 μm sterile filter membrane, adding equal volume of the filtrateCAS detection solution, standing for 1 hr, and measuring OD with full-wavelength microplate reader (MultiskaGO)630(As), OD of the liquid medium without inoculated bacteria was measured by the same method630As a reference value (denoted as "Ar"). The concentration of the siderophore is expressed by siderophore activity unit (SU), SU ═ Ar-As/Ar]X 100%, the assay was repeated 3 times, and the mean was taken for comparative analysis. As a result, as shown in Table 2, the siderophore productivity of the strain was 87.74% by the cultivation for 5 days. The same method was used to test the siderophore activity of different trichoderma strains, and the results are shown in table 1.
Table 2: quantitative determination of bacterial strain siderophore
|
Ar
|
As
|
As/Ar
|
Activity of siderophore%
|
2-14F2
|
4.48
|
0.55(0.02)
|
0.12(0.01)
|
87.74(0.002) |
Injecting; the data in the table are the mean (standard deviation) of the results of the soil sample analysis; ar; blank group at OD630Absorbance values (reference values); as; treatment group at OD630An absorbance value.
Example 3
This example illustrates the identification of the chemical structure type of siderophore compounds produced by the strains of the invention under study.
The identification method comprises the following steps:
identifying hydroxamic acid type siderophores; 1mL of 2% FeCl was added to 1mL of the culture filtrate3The appearance of a red or purple color in the solution indicates that the test sample contains the ferricarrier substance. When the detection is carried out by an ultraviolet spectrophotometer (EU-2200R), an absorption peak appears between 420 and 450nm, which indicates that the chelating substance is hydroxamic acid type siderophore. As a result, 2-14F2 strain was judged to produce hydroxamic acid type siderophore, as strain culture filtrates showed the highest peaks at 420-450 band after full-band scanning using a spectrophotometer (EU-2200R) (see FIG. 3).
Example 4
This example illustrates the culture of the strain and the extraction of fermentation metabolites according to the invention of the present study.
Selecting a fermentation formula as follows; sterilizing 10g, 25g, 50g, 100g steamed rice under high pressure, and packaging into 100ml, 250 ml, 500ml, 1000ml tissue culture bottles. The strains 2 to 14F2 (. times.10) were inoculated, respectively9CFU·ml-1) The bacterial suspension (2) was cultured in 100. mu.l, 250. mu.l, 500. mu.l, and 1000. mu.l at 28 ℃ in the dark for 45 days. Adding methanol into the fermentation product, soaking at 37 deg.C for 48h (1L/L of fermentation product methanol), dissolving, filtering with filter paper sheet and funnel, bottling, and selecting rotary evaporator (R-210BUCHI), setting temperature at 45 deg.C, and rotating at 700rpm/min until the organic solvent is completely evaporated. The result shows that a solid strain metabolite is obtained, and a raw material is provided for the subsequent antibacterial activity verification.
Example 5
This example illustrates the results of the bacterial wilt inhibition by the metabolites of the strains of the invention of this study.
The implementation method comprises the following steps:
replicate 3 for each strain using 96-well plate a/B/C/D/E/F/G/H rows, 1-12 columns of plate wells (e.g., a1, a2, A3.. a 12; B1, B2.. B12, etc.). Add 100. mu.l of NA liquid medium into the plate hole,then 100 mu L of diluted bacteriostatic solution to be tested (metabolite concentration is 20mg/mL) is respectively added into the first holes of the A/B two rows, blank control is set, 100 mu L of sterile water is added, then the bacteriostatic solution to be tested is fully blown and beaten (at least three times or more) by a pipette to fully and uniformly mix with the liquid culture medium, then 100 mu L of the bacteriostatic solution is sucked and added into the second holes, then the bacteriostatic solution is fully blown and beaten to fully and uniformly mix with the liquid culture medium, the operation is repeated until the last hole is reached, 100 mu L of the bacteriostatic solution is sucked and discarded, and then 100 mu L of bacterial suspension is added into the plate holes. Placing 96-well plate in 37 deg.C constant temperature incubator for 18h, and then labeling with enzyme OD625The absorbance was measured. Converted into turbidimetric concentration of Mycoplasma or approximate concentration of microorganisms (. times.10)8CFU/ml) to calculate the bactericidal (bacteriostatic) rate. The calculation formula is as follows: the inhibition ratio is "growth control group microorganism concentration (or turbidimetric concentration in my-maiden)" - "inhibition test group microorganism concentration (or turbidimetric concentration in my-maiden)"/"growth control group microorganism concentration (or turbidimetric concentration in my-maiden)" × 100%. The results show that: the metabolite concentration is reduced and the bacteriostatic activity (percentage) is reduced. The bacteriostatic activity of the metabolite aiming at different plant pathogenic bacteria such as pseudomonas solanacearum, pectobacterium carotovorum and ralstonia solanacearum strains is also obviously different. The metabolite concentrations were: 10 mg/ml-1,5mg·ml-1,2.5mg·ml-1,1.25mg·ml-1,0.625mg·ml-1,0.3125mg·ml-1,1.5625mg·ml-1,0.0781mg·ml-1,0.039mg·ml-1,0.019mg·ml-1,0.0097mg·ml-1And 0.004 mg/ml-1At each concentration, the bacteriostatic activity against pseudomonas solanacearum is 93%, 81%, 72%, 67%, 60%, 42%, 23%, 14%, 10%, 9%, 8%, 5%, the bacteriostatic activity against pseudomonas solanacearum is 93%, 80%, 70%, 65%, 60%, 41%, 22%, 13%, 10%, 9%, 5%, 5%, 5%, the bacteriostatic activity against pectobacterium carotovorum is 75%, 72%, 70%, 65%, 60%, 31%, 21%, 17%, 15%, 13%, 10%, 7%, the bacteriostatic activity against pseudomonas solanacearum is 87%, 78%, 73%, 63%, 52%, 32%, 26%, 13%, 10%, 10%, 7%, 4% (see fig. 4).
Example 6
This example illustrates the bacteriostatic effect of the metabolites of the strains of the invention on plant pathogens under iron supplementation.
The implementation method comprises the following steps: adding FeCl of 1mol/ml into metabolite of strain3Solution (Strain metabolite and FeCl)3The volume ratio of the solution is 1:1) to prepare a strain metabolite and FeCl with the concentration of 20mg/mL3The solution was repeated for each strain 3 using 96-well plates, rows a/B/C/D/E/F/G/H, 1-12 columns of wells (e.g., a1, a2, A3.. a 12; B1, B2.. B12, etc.). The minimum inhibitory concentrations (inhibitory rates) against Pseudomonas solanacearum, Pectinobacterium carotovorum and Ralstonia reyi were determined in the same manner as in the test method of example 5. The results show that: adding FeCl of 1mol/ml into metabolite of strain3After the solution, the bacteriostatic activity is remarkably reduced: the bacteriostatic activity of 2-14F2 strain metabolite against Pseudomonas solanacearum at high concentration (5mg/ml) is about 93%, while FeCl is added3Then, the antibacterial activity is reduced to 37%; the bacteriostatic activity of 2-14F2 strain metabolite against P.solanacearum at high concentration (5mg/ml) was about 93%, while FeCl was added3Then, the antibacterial activity is reduced to 36%; aiming at the bacteriostasis rate of the pectobacterium carotovorum under high concentration (5mg/ml) of about 75 percent, FeCl is added3Then, the bacteriostasis rate is reduced to 29 percent; aiming at the bacterial inhibition rate of ralstonia solanacearum under high concentration (5mg/ml) of 87 percent, FeCl is added3Then, the bacteriostatic rate decreased to 31% (see fig. 4). This phenomenon indicates that: the siderophore in the metabolite is in important connection with the 2-14F2 strain to play the bacteriostatic role.
Various embodiments of the present invention are described above in detail and result in preferred target pathogens, concentrations, etc., but the present invention is not limited thereto. Various simple modifications can be made to the technical scheme of the invention including the implementation method, technical conception, concentration ratio and the like, and various technical points, characteristics and any other ways can be combined, and the simple modifications and the combinations and the like are considered to be the contents disclosed by the invention and all belong to the protection scope of the invention.